Ionis Pharmaceuticals | IONS - Selling And Administration Expenses



Ionis Pharmaceuticals reported $90.6M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Adcock Ingram Holdings ZAR 1.05B 50.17M Dec/2024
Agios Pharmaceuticals USD 45.87M 4.34M Jun/2025
Alnylam Pharmaceuticals USD 323.31M 83.36M Jun/2025
Arrowhead Research USD 30.95M 3.06M Jun/2025
Astellas Pharma JPY 197B 14.32B Jun/2025
BioMarin Pharmaceutical USD 232.28M 26.16M Jun/2025
Celltrion KRW 276.8B 58.09B Mar/2025
Cspc Pharmaceutical CNY 1.89B 347.81M Mar/2025
Divis Laboratories Ltd 3.4B 10M Jun/2025
Exelixis USD 134.86M 2.32M Jul/2025
Halozyme Therapeutics USD 33M 9.36M Jun/2025
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
Kangmei Pharma CNY 259.36M 49.8M Jun/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 12.94M 5.87M Dec/2024
Moderna USD 230M 18M Jun/2025
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Neurocrine Biosciences USD 286.3M 9.8M Jun/2025
Novartis USD 3.44B 384M Jun/2025
OPKO Health USD 59.6M 7.4M Jun/2025
Organigram Holdings CAD 25.49M 8.3M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
Pharma Mar EUR 14.68M 1M Jun/2025
PTC Therapeutics USD 85.26M 76.66M Jun/2025
Qiagen NV USD 148.74M 10.8M Jun/2025
Regeneron Pharmaceuticals USD 634.2M 1.2M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Sarepta Therapeutics USD 69.89M 63.74M Jun/2025
Sartorius EUR 225.2M 6.7M Jun/2025
Sino Biopharmaceutical CNY 5.31B 1.54B Dec/2024
Tilray USD 72.38M 4.99M Nov/2024
Ultragenyx Pharmaceutical USD 86.65M 1.15M Jun/2025
Vertex Pharmaceuticals USD 424.6M 28.2M Jun/2025
Zz Pientze Pharmaceu -171290000 342.58M Jun/2025